Aurora kinase-IN-8, CAS [[1911629-44-1]]

Produktübersicht

• Artikelname: Aurora kinase-IN-8, CAS [[1911629-44-1]]
• Artikelnummer: MCE-HY-175866
• Hersteller Artikelnummer: HY-175866
• Alternativnummer: MCE-HY-175866-5MG,MCE-HY-175866-10MG,MCE-HY-175866-100MG,MCE-HY-175866-50MG,MCE-HY-175866-25MG
• Hersteller: MedchemExpress
• Kategorie: Biochemikalien

Produktbeschreibung

Aurora kinase-IN-8 is a orally active Aurora kinase inhibitor. Aurora kinase-IN-8 shows IC50 values of 2.8 and 28.1 nM against Aurora A kinase and Aurora B kinase. Aurora kinase-IN-8 can prevent spindle formation, cause G2/M phase arrest, and induce cell apoptosis. Aurora kinase-IN-8 can be used for the research of cancer, such as triple-negative breast cancer[1].

Produkteigenschaften

• Molekulargewicht: 425.53
• CAS Nummer: [1911629-44-1]
• Formel: C25H27N7
• Target-Kategorie: Apoptosis,Aurora Kinase

Anwendungsbeschreibung

• Anwendungsbeschreibung: MCE Product type: Reference compound